SCHEMBL238145

SCHEMBL238145

CC(NF)NF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6630211 0.74
Propane SCHEMBL29023790 0.64
SCHEMBL19443242 0.64
Hydrochloric Acid SCHEMBL28813812 0.61
SCHEMBL24447061 0.59
SCHEMBL5663486 0.57
SCHEMBL16408971 0.57
SCHEMBL579317 0.53
SCHEMBL706279 0.53
Isopropylhydroxylamine SCHEMBL64261 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180265514-A1 SALT OF CD80 ANTAGONIST MEDIGENE AG (DE) 2018-09-20 US disclosed
EP-1991548-B1 Salt of CD80 antagonist MEDIGENE AG (DE) 2013-12-11 EP disclosed
US-20120004237-A1 SALT OF CD 80 ANTAGONIST MEDIGENE AG (DE) 2012-01-05 US disclosed
US-20090221590-A1 SALT OF CD 80 ANTAGONIST MEDIGENE LIMITED (GB) 2009-09-03 US disclosed
EP-1991548-A1 SALT OF CD 80 ANTAGONIST MediGene Ltd. (GB) 2008-11-19 EP disclosed
WO-2007096588-A1 SALT OF CD 80 ANTAGONIST MEDIGENE LIMITED (GB) 2007-08-30 WO disclosed